Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

Polo Pureza, whose name translates from Spanish as "Polo Purity," was inducted into the Argentine Association of Polo Horse ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Vertex Pharmaceuticals Inc. (VRTX), a commercial-stage global biotechnology company, announced Friday a reimbursement agreement with ...

College of Life Science, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian 271016, China Science and Technology Innovation Center, Shandong First Medical University & ...

CRISPR-Cas9 technology has the potential to enhance photosynthetic efficiency and increase crop yields. CRISPR-Cas9 is a gene editing process where genetic engineers can target specific genes in the ...

The genetic code is universal in all organisms. It uses the same 4 bases to code for the same set of 20 amino acids to produce all proteins across all organisms. This suggests that all organisms are ...